Your browser doesn't support javascript.
loading
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.
Hodiamont, Caspar J; van den Broek, Annemieke K; de Vroom, Suzanne L; Prins, Jan M; Mathôt, Ron A A; van Hest, Reinier M.
Afiliación
  • Hodiamont CJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. c.j.hodiamont@amsterdamumc.nl.
  • van den Broek AK; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • de Vroom SL; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Prins JM; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Mathôt RAA; Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • van Hest RM; Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Clin Pharmacokinet ; 61(8): 1075-1094, 2022 08.
Article en En | MEDLINE | ID: mdl-35754071
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Gentamicinas / Enfermedad Crítica Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Gentamicinas / Enfermedad Crítica Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article